Harga Saham

Tanggal	Tianjin Pharmaceutical Da Ren Tang Group Corp Pendapatan	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT	Tianjin Pharmaceutical Da Ren Tang Group Corp Laba
2026e	10,96 miliar undefined	1,65 miliar undefined	1,73 miliar undefined
2025e	10,00 miliar undefined	1,34 miliar undefined	1,46 miliar undefined
2024e	9,12 miliar undefined	1,08 miliar undefined	1,21 miliar undefined
2023	8,22 miliar undefined	814,79 Juta. undefined	986,71 Juta. undefined
2022	8,25 miliar undefined	681,08 Juta. undefined	861,79 Juta. undefined
2021	6,91 miliar undefined	592,64 Juta. undefined	769,14 Juta. undefined
2020	6,60 miliar undefined	587,50 Juta. undefined	661,70 Juta. undefined
2019	6,99 miliar undefined	536,80 Juta. undefined	625,60 Juta. undefined
2018	6,36 miliar undefined	468,00 Juta. undefined	561,70 Juta. undefined
2017	5,69 miliar undefined	348,30 Juta. undefined	476,10 Juta. undefined
2016	6,24 miliar undefined	295,80 Juta. undefined	423,60 Juta. undefined
2015	7,08 miliar undefined	393,20 Juta. undefined	451,40 Juta. undefined
2014	7,09 miliar undefined	372,50 Juta. undefined	357,80 Juta. undefined
2013	6,01 miliar undefined	344,10 Juta. undefined	351,80 Juta. undefined
2012	5,13 miliar undefined	268,00 Juta. undefined	441,30 Juta. undefined
2011	4,39 miliar undefined	271,90 Juta. undefined	247,60 Juta. undefined
2010	3,47 miliar undefined	236,80 Juta. undefined	293,30 Juta. undefined
2009	2,88 miliar undefined	168,40 Juta. undefined	257,80 Juta. undefined
2008	2,37 miliar undefined	92,50 Juta. undefined	176,10 Juta. undefined
2007	2,26 miliar undefined	-185,70 Juta. undefined	-70,00 Juta. undefined
2006	2,16 miliar undefined	-408,20 Juta. undefined	-386,60 Juta. undefined
2005	2,52 miliar undefined	51,30 Juta. undefined	80,80 Juta. undefined
2004	2,12 miliar undefined	73,10 Juta. undefined	64,00 Juta. undefined

	Pendapatan	EBIT	Laba
2004	2,12 miliar CNY	73,10 Juta. CNY	64,00 Juta. CNY
2005	2,52 miliar CNY	51,30 Juta. CNY	80,80 Juta. CNY
2006	2,16 miliar CNY	-408,20 Juta. CNY	-386,60 Juta. CNY
2007	2,26 miliar CNY	-185,70 Juta. CNY	-70,00 Juta. CNY
2008	2,37 miliar CNY	92,50 Juta. CNY	176,10 Juta. CNY
2009	2,88 miliar CNY	168,40 Juta. CNY	257,80 Juta. CNY
2010	3,47 miliar CNY	236,80 Juta. CNY	293,30 Juta. CNY
2011	4,39 miliar CNY	271,90 Juta. CNY	247,60 Juta. CNY
2012	5,13 miliar CNY	268,00 Juta. CNY	441,30 Juta. CNY
2013	6,01 miliar CNY	344,10 Juta. CNY	351,80 Juta. CNY
2014	7,09 miliar CNY	372,50 Juta. CNY	357,80 Juta. CNY
2015	7,08 miliar CNY	393,20 Juta. CNY	451,40 Juta. CNY
2016	6,24 miliar CNY	295,80 Juta. CNY	423,60 Juta. CNY
2017	5,69 miliar CNY	348,30 Juta. CNY	476,10 Juta. CNY
2018	6,36 miliar CNY	468,00 Juta. CNY	561,70 Juta. CNY
2019	6,99 miliar CNY	536,80 Juta. CNY	625,60 Juta. CNY
2020	6,60 miliar CNY	587,50 Juta. CNY	661,70 Juta. CNY
2021	6,91 miliar CNY	592,64 Juta. CNY	769,14 Juta. CNY
2022	8,25 miliar CNY	681,08 Juta. CNY	861,79 Juta. CNY
2023	8,22 miliar CNY	814,79 Juta. CNY	986,71 Juta. CNY
2024e	9,12 miliar CNY	1,08 miliar CNY	1,21 miliar CNY
2025e	10,00 miliar CNY	1,34 miliar CNY	1,46 miliar CNY
2026e	10,96 miliar CNY	1,65 miliar CNY	1,73 miliar CNY

Tianjin Pharmaceutical Da Ren Tang Group Corp Margin Kotor	Tianjin Pharmaceutical Da Ren Tang Group Corp Margin Laba	Tianjin Pharmaceutical Da Ren Tang Group Corp Margin EBIT	Tianjin Pharmaceutical Da Ren Tang Group Corp Margin Laba
2026e	43,66 %	15,09 %	15,80 %
2025e	43,66 %	13,36 %	14,58 %
2024e	43,66 %	11,84 %	13,24 %
2023	43,66 %	9,91 %	12,00 %
2022	39,49 %	8,26 %	10,45 %
2021	39,76 %	8,58 %	11,13 %
2020	39,07 %	8,90 %	10,02 %
2019	41,76 %	7,68 %	8,94 %
2018	41,20 %	7,36 %	8,83 %
2017	38,68 %	6,12 %	8,37 %
2016	32,27 %	4,74 %	6,79 %
2015	29,48 %	5,55 %	6,38 %
2014	30,27 %	5,26 %	5,05 %
2013	31,86 %	5,73 %	5,85 %
2012	34,12 %	5,22 %	8,60 %
2011	34,85 %	6,19 %	5,64 %
2010	37,77 %	6,82 %	8,44 %
2009	37,54 %	5,85 %	8,95 %
2008	36,93 %	3,91 %	7,45 %
2007	34,28 %	-8,22 %	-3,10 %
2006	35,01 %	-18,86 %	-17,86 %
2005	42,58 %	2,04 %	3,21 %
2004	45,13 %	3,45 %	3,02 %

	Margin Kotor	Margin EBIT	Margin Laba
2004	45,13 %	3,45 %	3,02 %
2005	42,58 %	2,04 %	3,21 %
2006	35,01 %	-18,86 %	-17,86 %
2007	34,28 %	-8,22 %	-3,10 %
2008	36,93 %	3,91 %	7,45 %
2009	37,54 %	5,85 %	8,95 %
2010	37,77 %	6,82 %	8,44 %
2011	34,85 %	6,19 %	5,64 %
2012	34,12 %	5,22 %	8,60 %
2013	31,86 %	5,73 %	5,85 %
2014	30,27 %	5,26 %	5,05 %
2015	29,48 %	5,55 %	6,38 %
2016	32,27 %	4,74 %	6,79 %
2017	38,68 %	6,12 %	8,37 %
2018	41,20 %	7,36 %	8,83 %
2019	41,76 %	7,68 %	8,94 %
2020	39,07 %	8,90 %	10,02 %
2021	39,76 %	8,58 %	11,13 %
2022	39,49 %	8,26 %	10,45 %
2023	43,66 %	9,91 %	12,00 %
2024e	43,66 %	11,84 %	13,24 %
2025e	43,66 %	13,36 %	14,58 %
2026e	43,66 %	15,09 %	15,80 %

Tanggal	Tianjin Pharmaceutical Da Ren Tang Group Corp Pendapatan per Saham	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT per Saham	Tianjin Pharmaceutical Da Ren Tang Group Corp Laba per Saham
2026e	14,25 undefined	0 undefined	2,25 undefined
2025e	13,01 undefined	0 undefined	1,90 undefined
2024e	11,86 undefined	0 undefined	1,57 undefined
2023	10,69 undefined	1,06 undefined	1,28 undefined
2022	10,63 undefined	0,88 undefined	1,11 undefined
2021	8,98 undefined	0,77 undefined	1,00 undefined
2020	8,59 undefined	0,76 undefined	0,86 undefined
2019	9,10 undefined	0,70 undefined	0,81 undefined
2018	8,26 undefined	0,61 undefined	0,73 undefined
2017	7,40 undefined	0,45 undefined	0,62 undefined
2016	8,12 undefined	0,38 undefined	0,55 undefined
2015	9,21 undefined	0,51 undefined	0,59 undefined
2014	9,59 undefined	0,50 undefined	0,48 undefined
2013	8,13 undefined	0,47 undefined	0,48 undefined
2012	6,94 undefined	0,36 undefined	0,60 undefined
2011	5,94 undefined	0,37 undefined	0,33 undefined
2010	4,70 undefined	0,32 undefined	0,40 undefined
2009	3,90 undefined	0,23 undefined	0,35 undefined
2008	3,20 undefined	0,13 undefined	0,24 undefined
2007	3,05 undefined	-0,25 undefined	-0,09 undefined
2006	2,93 undefined	-0,55 undefined	-0,52 undefined
2005	3,40 undefined	0,07 undefined	0,11 undefined
2004	2,86 undefined	0,10 undefined	0,09 undefined

	Pendapatan per Saham	EBIT per Saham	Laba per Saham
2004	2,86 CNY	0,10 CNY	0,09 CNY
2005	3,40 CNY	0,07 CNY	0,11 CNY
2006	2,93 CNY	-0,55 CNY	-0,52 CNY
2007	3,05 CNY	-0,25 CNY	-0,09 CNY
2008	3,20 CNY	0,13 CNY	0,24 CNY
2009	3,90 CNY	0,23 CNY	0,35 CNY
2010	4,70 CNY	0,32 CNY	0,40 CNY
2011	5,94 CNY	0,37 CNY	0,33 CNY
2012	6,94 CNY	0,36 CNY	0,60 CNY
2013	8,13 CNY	0,47 CNY	0,48 CNY
2014	9,59 CNY	0,50 CNY	0,48 CNY
2015	9,21 CNY	0,51 CNY	0,59 CNY
2016	8,12 CNY	0,38 CNY	0,55 CNY
2017	7,40 CNY	0,45 CNY	0,62 CNY
2018	8,26 CNY	0,61 CNY	0,73 CNY
2019	9,10 CNY	0,70 CNY	0,81 CNY
2020	8,59 CNY	0,76 CNY	0,86 CNY
2021	8,98 CNY	0,77 CNY	1,00 CNY
2022	10,63 CNY	0,88 CNY	1,11 CNY
2023	10,69 CNY	1,06 CNY	1,28 CNY
2024e	11,86 CNY	0 CNY	1,57 CNY
2025e	13,01 CNY	0 CNY	1,90 CNY
2026e	14,25 CNY	0 CNY	2,25 CNY

	Jumlah Saham
2004	739,30 Juta. Aktien
2005	739,30 Juta. Aktien
2006	739,30 Juta. Aktien
2007	739,30 Juta. Aktien
2008	739,30 Juta. Aktien
2009	739,30 Juta. Aktien
2010	739,30 Juta. Aktien
2011	739,30 Juta. Aktien
2012	739,30 Juta. Aktien
2013	739,30 Juta. Aktien
2014	739,30 Juta. Aktien
2015	768,90 Juta. Aktien
2016	768,90 Juta. Aktien
2017	768,90 Juta. Aktien
2018	769,40 Juta. Aktien
2019	768,90 Juta. Aktien
2020	768,90 Juta. Aktien
2021	769,14 Juta. Aktien
2022	776,39 Juta. Aktien
2023	768,87 Juta. Aktien
2024e	768,87 Juta. Aktien
2025e	768,87 Juta. Aktien
2026e	768,87 Juta. Aktien

Tanggal	Tianjin Pharmaceutical Da Ren Tang Group Corp Dividen
2026e	1,21 undefined
2025e	1,21 undefined
2024e	1,21 undefined
2023	1,12 undefined
2022	0,50 undefined
2021	0,30 undefined
2020	0,30 undefined
2019	0,22 undefined
2018	0,20 undefined
2017	0,15 undefined
2016	0,25 undefined
2015	0,15 undefined
2014	0,05 undefined
2013	0,10 undefined
2012	0,20 undefined
2011	0,20 undefined
2006	0,08 undefined
2005	0,08 undefined
2004	0,08 undefined

	Dividen	Dividen (Estimasi)
2004	0,08 CNY	0 CNY
2005	0,08 CNY	0 CNY
2006	0,08 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0,20 CNY	0 CNY
2012	0,20 CNY	0 CNY
2013	0,10 CNY	0 CNY
2014	0,05 CNY	0 CNY
2015	0,15 CNY	0 CNY
2016	0,25 CNY	0 CNY
2017	0,15 CNY	0 CNY
2018	0,20 CNY	0 CNY
2019	0,22 CNY	0 CNY
2020	0,30 CNY	0 CNY
2021	0,30 CNY	0 CNY
2022	0,50 CNY	0 CNY
2023	1,12 CNY	0 CNY
2024e	0 CNY	1,21 CNY
2025e	0 CNY	1,21 CNY
2026e	0 CNY	1,21 CNY

Tanggal	Tianjin Pharmaceutical Da Ren Tang Group Corp Rasio Pembayaran Dividen
2026e	37,84 %
2025e	39,64 %
2024e	37,23 %
2023	36,64 %
2022	45,05 %
2021	30,00 %
2020	34,88 %
2019	27,16 %
2018	27,40 %
2017	24,19 %
2016	45,45 %
2015	25,42 %
2014	10,42 %
2013	20,83 %
2012	33,33 %
2011	60,61 %
2010	36,64 %
2009	36,64 %
2008	36,64 %
2007	36,64 %
2006	-14,42 %
2005	68,18 %
2004	83,33 %

	Rasio Pembayaran Dividen
2004	83,33 %
2005	68,18 %
2006	-14,42 %
2007	36,64 %
2008	36,64 %
2009	36,64 %
2010	36,64 %
2011	60,61 %
2012	33,33 %
2013	20,83 %
2014	10,42 %
2015	25,42 %
2016	45,45 %
2017	24,19 %
2018	27,40 %
2019	27,16 %
2020	34,88 %
2021	30,00 %
2022	45,05 %
2023	36,64 %
2024e	37,23 %
2025e	39,64 %
2026e	37,84 %

Tanggal	Estimasi EPS	EPS-Actual	Kuartal Laporan
31/12/2014	0,22	0,13 (-41,49 %)	2014 Q4
30/9/2014	0,18	0,08 (-56,00 %)	2014 Q3
30/6/2014	0,15	0,13 (-14,19 %)	2014 Q2
31/12/2013	0,21	0,16 (-24,56 %)	2013 Q4
30/9/2013	0,14	0,06 (-57,57 %)	2013 Q3
30/6/2013	0,13	0,10 (-20,82 %)	2013 Q2

%	Nama	Saham	Perubahan	Tanggal
42,38 %	Tianjin Pharmaceutical Holdings Ltd.	325.855.528	0	31/12/2023
1,09 %	Fullgoal Fund Management Co., Ltd.	8.392.119	-340.800	31/12/2023
0,70 %	Zhong Ou Asset Management Co., Ltd.	5.348.982	-8.489.300	31/12/2023
0,61 %	GF Fund Management Co., Ltd.	4.711.501	-1.989.900	31/12/2023
0,57 %	Chen (Shihui)	4.418.118	4.418.118	31/12/2023
0,54 %	China Universal Asset Management Co., Ltd.	4.124.015	-422.094	31/12/2023
0,31 %	Hotland Innovation Asset Management Co., Ltd.	2.413.803	-230.080	31/12/2023
0,29 %	E Fund Management Co. Ltd.	2.252.050	-2.748.720	30/6/2023
0,29 %	China Southern Asset Management Co. Ltd.	2.228.492	117.800	31/12/2023
0,27 %	ICBC Credit Suisse Asset Management Co. Ltd.	2.107.589	-243.100	31/12/2023
0,23 %	Cinda Fund Management Co., Ltd.	1.805.256	-2.020.600	31/12/2023
0,22 %	China Asset Management Co., Ltd.	1.722.109	53.900	31/12/2023
0,21 %	Bosera Asset Management Co., Ltd.	1.589.300	-30.200	31/12/2023
0,20 %	Penghua Fund Management Co., Ltd.	1.510.738	310.800	30/6/2023
0,19 %	ZhongRong Fund Mgmt Co., Ltd	1.434.538	-638.862	30/6/2023
0,17 %	The Vanguard Group, Inc.	1.311.297	0	31/3/2024
0,16 %	JPMorgan Asset Management (China) Company Limited.	1.254.249	1.214.649	30/6/2023
0,15 %	China Merchants Fund Management Co. Ltd.	1.153.883	-160.300	31/12/2023
0,14 %	Western Leadbank Fund Management Co., Ltd.	1.040.100	1.040.100	30/6/2023
0,12 %	CCB Principal Asset Management Co., Ltd.	913.135	103.700	31/12/2023
0,11 %	AXA-SPDB Investment Managers Co., Ltd.	813.400	695.400	31/12/2023
0,10 %	Harvest Fund Management Co., Ltd.	803.209	-741.615	30/6/2023
0,09 %	Guotai Junan Securities Assets Management Co., Ltd.	692.400	692.400	30/6/2023
0,09 %	Broad Asset Management Co., Ltd	686.600	686.600	30/6/2023
0,08 %	Great Wall Fund Management Co., Ltd.	628.300	-21.700	31/12/2023
0,08 %	Tianhong Asset Management Co., Ltd.	579.300	14.300	31/12/2023
0,07 %	CITIC Prudential Fund Management Co., Ltd.	560.672	500.000	31/12/2023
0,07 %	Zhong Hai Fund Management Co., Ltd.	548.127	548.127	31/12/2023
0,06 %	Changsheng Fund Management Co., Ltd.	498.100	-25.400	31/12/2023
0,06 %	Morgan Stanley Investment Management (China) Company Limited.	480.200	30.300	30/6/2023
0,06 %	Founder Fubon Fund Management Co., Ltd.	460.677	0	31/12/2023
0,06 %	Norges Bank Investment Management (NBIM)	458.108	458.108	31/12/2023
0,05 %	First-Trust Fund Management Co., Ltd.	388.188	-157.228	30/6/2023
0,05 %	Hongde Fund Management Co., Ltd.	349.200	-696.900	30/6/2023
0,04 %	Bank of Communications Schroder Fund Management Co., Ltd.	297.773	-5.088.456	30/6/2023
0,04 %	Baoying Fund Management Co., Ltd.	273.100	-499.300	31/12/2023
0,03 %	Dacheng Fund Management Co., Ltd.	260.201	256.600	30/6/2023
0,03 %	Value Partners Ltd.	246.572	-41.400	31/12/2023
0,03 %	Maxwealth Fund Management Co., Ltd.	220.000	218.100	30/6/2023
0,03 %	Chang Xin Asset Management Co., Ltd.	212.000	-269.200	31/12/2023
0,03 %	PengYang Asset Management Co., Ltd	207.000	207.000	30/6/2023
0,03 %	Huashang Fund Management Co., Ltd.	200.000	200.000	30/6/2023
0,03 %	Dimensional Fund Advisors, L.P.	198.372	-200	29/2/2024
0,03 %	Yinhua Fund Management Co., Ltd.	198.031	125.400	31/12/2023
0,03 %	Everbright PGIM Fund Management Co., Ltd.	197.000	-179.100	30/6/2023
0,02 %	CICC Fund Management Co Ltd.	170.700	-6.500	31/12/2023
0,02 %	INVESCO Great Wall Fund Management Co. Ltd.	167.255	-3.200	31/12/2023
0,02 %	Wanjia Asset Management Co., Ltd.	167.159	-2.781.983	30/6/2023
0,02 %	BOC International (China) Ltd.	142.800	200	31/12/2023
0,02 %	Hwabao WP Fund Management Co., Ltd.	116.000	90.000	31/12/2023
0,01 %	Huatai-PineBridge Fund Management Co., Ltd.	112.780	-214.603	30/6/2023
0,01 %	TongTai Asset Management Co., Ltd.	103.700	103.700	30/6/2023
0,01 %	Focusbridge Investments Limited	98.000	98.000	30/6/2023
0,01 %	Orient Securities Asset Management Company Limited	95.600	95.600	30/6/2023
0,01 %	Handelsbanken Kapitalförvaltning AB	95.500	0	31/3/2024
0,01 %	UBS SDIC Fund Management Co., Ltd.	92.800	15.100	31/12/2023
0,01 %	BOSC Asset Management Co., Ltd.	87.700	-33.600	31/12/2023
0,01 %	Ping An Fund Management Company Limited	77.400	-6.200	31/12/2023
0,01 %	ABC-CA Fund Management Co., Ltd.	68.100	-2.897.300	31/12/2023
0,01 %	Xinghua Fund Management Co., Ltd.	48.200	48.200	30/6/2023
0,01 %	Soochow Asset Management Co., Ltd.	47.200	-34.900	31/12/2023
0,01 %	China Fund Management Co., Ltd.	41.600	-28.600	31/12/2023
0,01 %	Guotai Asset Management Co., Ltd.	38.700	-445.509	30/6/2023
0,00 %	BlackRock Investment Management (UK) Ltd.	38.200	0	29/2/2024
0,00 %	SWS MU Fund Management Co., Ltd.	33.300	33.300	30/6/2023
0,00 %	JX Asset Management Co., Ltd.	32.078	-84.800	30/6/2023
0,00 %	Topsperity Fund Management Co., Ltd.	31.900	22.300	31/12/2023
0,00 %	Taikang Asset Management Co., Ltd.	28.100	25.000	31/12/2023
0,00 %	CITIC Securities Co., Ltd. (Asset Management)	27.600	27.600	30/6/2023
0,00 %	Donghai Funds Management Co., Ltd.	26.800	26.800	30/6/2023
0,00 %	Manulife Fund Management Co., Ltd.	25.700	1.000	31/12/2023
0,00 %	Sealand Securities Co., Ltd.	23.849	14.349	30/6/2023
0,00 %	Zhou (Hong)	23.800	-46.200	31/12/2023
0,00 %	Wang (Xin)	23.800	-46.200	31/12/2023
0,00 %	Niu (Sheng Fang)	23.800	-46.200	31/12/2023
0,00 %	Horizon Asset Management Co., Ltd.	20.700	-4.100	30/6/2023
0,00 %	AVIC Fund Management Co., Ltd.	18.700	12.600	30/6/2023
0,00 %	Caitong Fund Management Co., Ltd.	18.100	-31.200	31/12/2023
0,00 %	China Life AMP Asset Management Co., Ltd	17.200	-300	31/12/2023
0,00 %	China Everbright Assets Management, Ltd.	17.000	17.000	30/6/2023
0,00 %	HuaAn Fund Management Co., Ltd.	16.900	-1.328.600	30/6/2023
0,00 %	Goldstate Capital Fund Management Co., Ltd.	15.000	15.000	30/6/2023
0,00 %	CPIC Fund Management Co., Ltd.	14.500	14.500	30/6/2023
0,00 %	DBX Advisors LLC.	13.900	13.900	29/2/2024
0,00 %	Nykredit Bank AS	13.400	0	29/2/2024
0,00 %	Dimensional Fund Advisors, Ltd.	13.000	-6.600	29/2/2024
0,00 %	Minsheng Royal Fund Management Company Ltd.	12.200	4.800	30/6/2023
0,00 %	Neuberger Berman Fund Management (China) Co., Ltd.	11.739	11.739	30/6/2023
0,00 %	Truvalue Asset Management Co., Ltd.	10.500	-1.186.838	30/6/2023
0,00 %	Jiao (Yan)	10.200	-19.800	31/12/2023
0,00 %	Shanghai Haitong Securities Asset Management Ltd.	10.100	-3.800	31/12/2023
0,00 %	Tibet Eastmoney Fund Management Co., Ltd.	9.500	-100	30/6/2023
0,00 %	Xingyin Fund Management Co., Ltd.	9.300	9.300	30/6/2023
0,00 %	Orient Fund Management Co. Ltd.	9.000	-70.000	30/6/2023
0,00 %	Harvest Global Investments Limited	7.162	0	29/2/2024
0,00 %	Jyah Asset Management.Co.,LTD	7.000	5.500	30/6/2023
0,00 %	Golden Trust Sinopac Fund Management Co., Ltd.	6.500	6.500	30/6/2023
0,00 %	Essence Fund Management Co., Ltd.	6.100	-9.400	31/12/2023
0,00 %	Everbright Securities Asset Management Co., Ltd.	5.800	-5.900	31/12/2023
0,00 %	Northeast Ronghui Securities Asset Management Co., Ltd.	4.900	4.900	30/6/2023

Nama	Hubungan	Korelasi Dua Minggu	Korelasi Satu Bulan	Korelasi Tiga Bulan	Korelasi Enam Bulan	Korelasi Satu Tahun	Korelasi Dua Tahun
Citigroup	PemasokPelanggan	0,69	-0,04	0,80	0,66	0,43	0,57
GlaxoSmithKline	PemasokPelanggan	0,36	-0,43	-0,80	-0,59	-0,42	0,31
Standard Chartered	PemasokPelanggan	0,33	0,71	-0,68	-0,32	-0,34	0,26
Tianjin Lisheng Pharm A	PemasokPelanggan	0,12	0,91	0,83	0,28	0,17	-0,40
Tianjin Development Hldgs	PemasokPelanggan	0,05	-0,58	0,72	0,34	0,18	0,54
DBS Group Holdings	PemasokPelanggan	-0,53	-0,72	0,53	0,47	0,02	0,75
ABN AMRO DR	PemasokPelanggan	-0,70	-0,75	-0,21	0,60	0,30	0,78

What values and corporate philosophy does Tianjin Pharmaceutical Da Ren Tang Group Corp represent?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd represents values of innovation, integrity, and quality in the pharmaceutical industry. With a strong corporate philosophy focused on delivering cutting-edge healthcare solutions, the company strives to provide safe and effective pharmaceutical products to improve people's well-being. Tianjin Zhongxin Pharmaceutical Group Corp Ltd's commitment to research and development, along with its dedication to meeting international standards, has positioned the company as a leader in the global pharmaceutical market. Through its emphasis on quality control, continuous improvement, and customer satisfaction, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the delivery of reliable and trustworthy healthcare solutions.

In which countries and regions is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily present?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is primarily present in China.

What significant milestones has the company Tianjin Pharmaceutical Da Ren Tang Group Corp achieved?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd has achieved several significant milestones. It has successfully expanded its product portfolio, notably in the areas of cardiovascular, respiratory, and anti-infective medicines. The company has also secured numerous international certifications, including Good Manufacturing Practice (GMP) certification, ensuring the highest quality standards. Tianjin Zhongxin Pharmaceutical Group Corp Ltd has made remarkable strides in research and development as well, with several innovative drugs being registered and commercialized. Furthermore, the company has established a robust global presence by entering into strategic partnerships and expanding its market reach. These achievements consolidate Tianjin Zhongxin Pharmaceutical Group Corp Ltd's position as a leading player in the pharmaceutical industry.

What is the history and background of the company Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, a leading pharmaceutical company, has a rich history and background. Established in [year], the company has been dedicated to providing high-quality healthcare products and services to global markets. With a focus on research and development, manufacturing, and marketing, Tianjin Zhongxin has emerged as a trusted name in the pharmaceutical industry. Its commitment to innovation, quality, and customer satisfaction has enabled it to expand its presence both domestically and internationally. Being one of the prominent players in the pharmaceutical market, Tianjin Zhongxin Pharmaceutical Group Corp Ltd continuously strives for excellence through its diverse product portfolio and relentless pursuit of breakthrough solutions in healthcare.

Who are the main competitors of Tianjin Pharmaceutical Da Ren Tang Group Corp in the market?

The main competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd in the market include other leading pharmaceutical companies such as Shanghai Pharmaceuticals Holding Co., Ltd., Sinopharm Group Co., Ltd., Fosun Pharma, and Jiangsu Hengrui Medicine Co., Ltd.

In which industries is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily active?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd primarily operates in the pharmaceutical industry.

What is the business model of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd focuses on the development, production, and sales of pharmaceutical products. As one of the leading pharmaceutical companies in China, Tianjin Zhongxin Pharmaceutical Group Corp Ltd aims to provide high-quality and affordable medications to improve the health and well-being of individuals. With a diverse product portfolio ranging from traditional Chinese medicine to modern pharmaceuticals, the company emphasizes research and innovation to meet the growing healthcare needs of its customers. By adhering to strict quality standards and maintaining a strong distribution network, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the availability and accessibility of its products nationwide.

Berapa KGV dari Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Rasio P/E Tianjin Pharmaceutical Da Ren Tang Group Corp adalah 20,79.

KUV apa yang dimiliki oleh Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Rasio KUV dari Tianjin Pharmaceutical Da Ren Tang Group Corp adalah 2,75.

Skor Kualitas AlleAktien apa yang dimiliki oleh Tianjin Pharmaceutical Da Ren Tang Group Corp?

Skor Kualitas AlleAktien untuk Tianjin Pharmaceutical Da Ren Tang Group Corp adalah 7/10.

Berapa jumlah pendapatan dari Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Omset diharapkan Tianjin Pharmaceutical Da Ren Tang Group Corp adalah 9,12 miliar CNY.

Berapa besar keuntungan dari Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

Laba diharapkan Tianjin Pharmaceutical Da Ren Tang Group Corp adalah 1,21 miliar CNY.

Apa yang dilakukan Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is a Chinese company specialized in the production and sale of pharmaceutical products, health and dietary supplements, and medical devices. Its business model is based on a comprehensive range of products and services that allow it to meet the needs of customers in different markets. The company is divided into several divisions, including the pharmaceutical products division, the dietary supplements division, and the medical devices division. Each of these divisions offers unique products and services tailored to specific needs and requirements. In the field of pharmaceutical products, Tianjin Zhongxin Pharmaceutical Group Corp Ltd manufactures a variety of drugs used to treat various diseases and conditions. This includes antibiotics, anti-inflammatory drugs, cancer medications, as well as treatments for cardiovascular diseases and diabetes. The company also has a research and development department that continuously works on the development of new drugs. The dietary supplements division offers a wide range of products aimed at improving health and well-being. These include vitamins, minerals, enzymes, and herbal extracts. The company adheres to strict standards in the production of its products and uses only high-quality and natural ingredients. The medical devices division of Tianjin Zhongxin Pharmaceutical Group Corp Ltd specializes in the production of medical devices such as blood glucose monitors and blood pressure monitors. These devices are of high quality and comply with all applicable standards and regulations. The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd also includes collaborations with other companies and organizations around the world. The company has partnerships with a variety of domestic and international companies to expand its product range and strengthen its global presence. Overall, the business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is focused on the development, production, and sale of high-quality pharmaceutical products, dietary supplements, and medical devices. Its divisions offer a wide range of products and services tailored to the needs of customers in different markets. Through its global presence and collaborations with other companies and organizations worldwide, the company ensures continuous expansion and future success.

Berapa besar dividen Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Pharmaceutical Da Ren Tang Group Corp membayarkan dividen sebesar 0,50 CNY yang dibagi melalui pembayaran dalam setahun.

Berapa kali Tianjin Pharmaceutical Da Ren Tang Group Corp membayar dividen?

Dividen untuk Tianjin Pharmaceutical Da Ren Tang Group Corp saat ini tidak dapat dihitung atau perusahaan tidak membagikan dividen.

Apa itu ISIN Tianjin Pharmaceutical Da Ren Tang Group Corp?

ISIN dari Tianjin Pharmaceutical Da Ren Tang Group Corp adalah CNE000001808.

Apa itu Ticker Tianjin Pharmaceutical Da Ren Tang Group Corp?

Ticker dari Tianjin Pharmaceutical Da Ren Tang Group Corp adalah 600329.SS.

Berapa banyak Dividen yang dibayarkan oleh Tianjin Pharmaceutical Da Ren Tang Group Corp?

Dalam 12 bulan terakhir, Tianjin Pharmaceutical Da Ren Tang Group Corp membayar dividen sebesar 1,12 CNY . Ini setara dengan yield dividen sekitar 3,43 %. Untuk 12 bulan mendatang, Tianjin Pharmaceutical Da Ren Tang Group Corp diperkirakan akan membayar dividen sebesar 1,21 CNY.

Berapa tingkat dividen dari Tianjin Pharmaceutical Da Ren Tang Group Corp?

Imbal hasil dividen dari Tianjin Pharmaceutical Da Ren Tang Group Corp saat ini adalah 3,43 %.

Kapan Tianjin Pharmaceutical Da Ren Tang Group Corp membayar dividen?

Tianjin Pharmaceutical Da Ren Tang Group Corp membayar dividen setiap kuartal. Dividen ini dibayarkan pada bulan Juli, Juli, Juli, Juli.

Seberapa aman dividen dari Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Pharmaceutical Da Ren Tang Group Corp membayar dividen setiap tahun dalam 16 tahun terakhir.

Berapa besar dividen dari Tianjin Pharmaceutical Da Ren Tang Group Corp?

Untuk 12 bulan ke depan, diperkirakan akan ada dividen sebesar 1,21 CNY. Ini setara dengan yield dividen sebesar 3,70 %.

Di sektor manakah Tianjin Pharmaceutical Da Ren Tang Group Corp berada?

Tianjin Pharmaceutical Da Ren Tang Group Corp dikelompokkan dalam sektor 'Kesehatan'.

Wann musste ich die Aktien von Tianjin Pharmaceutical Da Ren Tang Group Corp kaufen, um die vorherige Dividende zu erhalten?

Untuk menerima dividen terakhir dari Tianjin Pharmaceutical Da Ren Tang Group Corp tanggal 6/6/2023 sejumlah 1,12 CNY, Anda harus memiliki saham tersebut di portofolio sebelum tanggal Ex-Tag pada 6/6/2023.

Kapan Tianjin Pharmaceutical Da Ren Tang Group Corp membayar dividen terakhir?

Pembayaran dividen terakhir dilakukan pada 6/6/2023.

Berapa besarnya dividen dari Tianjin Pharmaceutical Da Ren Tang Group Corp pada tahun 2023?

Pada tahun 2023, Tianjin Pharmaceutical Da Ren Tang Group Corp 0,5 CNY telah dibayarkan sebagai dividen.

Dalam mata uang apa Tianjin Pharmaceutical Da Ren Tang Group Corp membayar dividen?

Dividen dari Tianjin Pharmaceutical Da Ren Tang Group Corp dibayarkan dalam CNY.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	769,00	861,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	123,00	114,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10,00	-56,00
-84,00	-198,00	-353,00	-350,00	-462,00	-536,00	-667,00	-682,00	-493,00	-471,00	-629,00	-611,00	-737,00	-884,00	-1.370,00	-1.547,00	-1.679,00	-1.664,00	-1.816,00	-2.084,00	-2.305,00	-2.068,00	-2.316,00	-2.255,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-186,00	-191,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-59,00	-93,00	-146,00	-162,00	-180,00	-203,00	-178,00	-198,00	-197,00	-260,00	-254,00	-328,00	-374,00	-424,00	-495,00	-511,00	-505,00	-487,00	-514,00	-554,00	-598,00	-523,00	-496,00	-526,00
69,00	-14,00	157,00	187,00	76,00	10,00	261,00	-28,00	20,00	113,00	83,00	139,00	173,00	20,00	213,00	286,00	360,00	417,00	-4,00	350,00	495,00	671,00	852,00	677,00
-54,00	-79,00	-134,00	-180,00	-589,00	-252,00	-149,00	-63,00	-53,00	-38,00	-86,00	-68,00	-43,00	-41,00	-72,00	-70,00	-92,00	-118,00	-114,00	-175,00	-205,00	-189,00	-156,00	-107,00
74,00	22,00	-67,00	-114,00	-654,00	-109,00	-61,00	120,00	253,00	97,00	22,00	11,00	33,00	22,00	-166,00	102,00	-428,00	86,00	197,00	382,00	-100,00	73,00	-311,00	-12,00
128,00	101,00	66,00	65,00	-65,00	143,00	88,00	184,00	307,00	135,00	108,00	80,00	76,00	63,00	-93,00	172,00	-335,00	204,00	311,00	557,00	104,00	262,00	-154,00	95,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-22,00	-1,00	-244,00	51,00	564,00	114,00	64,00	-51,00	-145,00	-162,00	-49,00	-80,00	5,00	63,00	185,00	-273,00	-367,00	-19,00	-42,00	-10,00	-222,00	0	0	179,00
14,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-83,00	-85,00	54,00	-22,00	505,00	-4,00	-67,00	-187,00	-234,00	-246,00	-86,00	-120,00	-197,00	-75,00	266,00	-491,00	273,00	-339,00	-161,00	-252,00	-370,00	-237,00	-244,00	-236,00
-75,00	-83,00	369,00	22,00	28,00	9,00	5,00	0	0	0	19,00	4,00	1,00	0	239,00	-99,00	784,00	-114,00	8,00	-77,00	25,00	-4,00	-12,00	-29,00
0	0	-69,00	-96,00	-87,00	-128,00	-136,00	-136,00	-89,00	-84,00	-56,00	-45,00	-204,00	-138,00	-157,00	-118,00	-143,00	-205,00	-127,00	-164,00	-173,00	-232,00	-232,00	-387,00
0,27	0,20	0,80	0,75	0,65	0,65	1,24	0,76	0,75	0,81	0,99	1,11	1,30	1,30	2,39	2,24	2,75	2,73	2,36	3,47	3,42	3,77	3,96	3,89
14,80	-93,90	23,70	7,20	-512,60	-241,80	112,10	-91,80	-33,60	75,40	-3,30	70,20	130,90	-20,40	141,00	216,70	268,00	299,60	-118,40	174,30	289,90	482,20	695,45	569,34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Emisi Langsung.	—
Emisi tidak langsung dari energi yang dibeli.	—
Emisi tidak langsung dalam rantai nilai	—
Emisi CO₂	—
Strategi Reduksi CO₂	✅
Energi Batubara	❌
Energi Nuklir	❌
Percobaan pada hewan	✅
Bulu & Kulit	—
Pestisida	—
Minyak Sawit	—
Tembakau	❌
Bioteknologi	❌
Konsep Iklim	—
Pengelolaan Hutan Berkelanjutan	—
Peraturan Daur Ulang	❌
Kemasan Ramah Lingkungan	❌
Bahan berbahaya	❌
Konsumsi dan Efisiensi Bahan Bakar	❌
Penggunaan dan Efisiensi Air	✅

Persentase Karyawan Wanita	—
Proporsi Wanita dalam Manajemen	—
Porsi Karyawan Asia	—
Porsi Manajemen Asia	—
Proporsi Karyawan Hispanik/Latino	—
Porsi Manajemen Hispanik/Latino	—
Porsi Karyawan Berkulit Hitam	—
Porsi Manajemen Hitam	—
Proporsi Karyawan Kulit Putih	—
Porsi manajemen berkulit putih	—
Konten Dewasa	❌
Alkohol	❌
Pertahanan	—
Senjata api	❌
Judi	❌
Kontrak Militer	❌
Konsep Hak Asasi Manusia	❌
Konsep Perlindungan Data	—
Kesehatan dan Keselamatan Kerja	✅
Katolik	✅

Laporan Keberlanjutan	✅
Stakeholder-Engagement	❌
Kebijakan Pemanggilan Kembali	❌
Hukum Anti Monopoli	❌

Tianjin Pharmaceutical Da Ren Tang Group Corp Ticker	Tianjin Pharmaceutical Da Ren Tang Group Corp FIGI
600329:CH	BBG000CWRRB4
600329:CG	BBG000CWRRX0
600329:C1	BBG00709HMS7

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,29	0,41	0,82	1,52	1,84	2,06	2,12	2,52	2,16	2,26	2,37	2,88	3,47	4,39	5,13	6,01	7,09	7,08	6,24	5,69	6,36	6,99	6,60	6,91	8,25	8,22	9,12	10,00	10,96
-	44,06	99,51	85,04	20,91	12,23	2,47	19,01	-14,02	4,34	4,74	21,78	20,59	26,43	16,81	17,18	17,90	-0,08	-11,84	-8,86	11,76	9,99	-5,58	4,60	19,43	-0,33	10,92	9,66	9,58
49,65	50,49	42,58	37,48	36,81	41,72	45,11	42,55	34,98	34,28	36,91	37,53	37,75	34,84	34,12	31,85	30,27	29,48	32,27	38,67	41,19	41,76	39,07	39,76	39,48	43,66	-	-	-
0,14	0,21	0,35	0,57	0,68	0,86	0,95	1,07	0,76	0,77	0,87	1,08	1,31	1,53	1,75	1,91	2,15	2,09	2,01	2,20	2,62	2,92	2,58	2,75	3,26	3,59	0	0	0
0,03	0,04	0,04	0,06	0,06	0,07	0,07	0,05	-0,41	-0,19	0,09	0,17	0,24	0,27	0,27	0,34	0,37	0,39	0,30	0,35	0,47	0,54	0,59	0,59	0,68	0,81	1,08	1,34	1,65
11,19	9,71	4,50	3,81	3,15	3,54	3,45	2,03	-18,85	-8,19	3,89	5,83	6,80	6,17	5,23	5,72	5,25	5,55	4,73	6,12	7,36	7,66	8,89	8,57	8,26	9,90	11,84	13,36	15,09
0,15	0,11	0,09	0,06	0,09	0,09	0,06	0,08	-0,39	-0,07	0,18	0,26	0,29	0,25	0,44	0,35	0,36	0,45	0,42	0,48	0,56	0,63	0,66	0,77	0,86	0,99	1,21	1,46	1,73
-	-22,45	-24,56	-26,74	34,92	1,18	-25,58	25,00	-582,50	-81,87	-351,43	46,02	14,01	-15,70	78,54	-20,41	1,71	26,33	-6,21	12,53	17,86	11,41	5,76	16,34	11,96	14,52	22,41	20,80	18,72
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
659,30	659,30	659,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	739,30	768,90	768,90	768,90	769,40	768,90	768,90	769,14	776,39	768,87	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Lakukan investasi terbaik dalam hidupmu

Harga saham

Harga saham

Ticker600329.SS

ISINCNE000001808

Tianjin Pharmaceutical Da Ren Tang Group Corp Saham Pendapatan, EBIT, Laba CNE000001808 ·

Pendapatan, Laba & EBIT

Pemahaman Pendapatan, EBIT dan Penghasilan

Analisis Tahunan dan Perbandingan

Memanfaatkan Harapan Investasi

Wawasan Investasi

Tianjin Pharmaceutical Da Ren Tang Group Corp Omzet, Laba, dan Histori EBIT

Tianjin Pharmaceutical Da Ren Tang Group Corp Saham Kennzahlen

GuV

Pendapatan dan Pertumbuhan

Margin Bruto

EBIT dan Margin EBIT

Pendapatan dan Pertumbuhan

Saham yang Beredar

Interpretasi Perbandingan Tahunan

Ekspektasi dan Prakiraan

Neraca

Memahami Neraca

Aset

Kewajiban

Ekuitas

Analisis Tahun Demi Tahun

Interpretasi Data

Tianjin Pharmaceutical Da Ren Tang Group Corp Saham Marjin CNE000001808 ·

Margen

Pemahaman Margin Kotor

Analisis Margin EBIT

Wawasan Margin Penjualan

Menginterpretasikan Harapan

Analisis Komparatif

Tianjin Pharmaceutical Da Ren Tang Group Corp Sejarah Margin

Tianjin Pharmaceutical Da Ren Tang Group Corp Saham Pendapatan, EBIT, Laba per Saham CNE000001808 ·

Pendapatan, EBIT dan Laba per Saham

Pendapatan per Saham

EBIT per Saham

Pendapatan per Saham

Nilai yang Diharapkan

Tianjin Pharmaceutical Da Ren Tang Group Corp Pendapatan, Laba, dan EBIT per Saham Sejarah

Tianjin Pharmaceutical Da Ren Tang Group Corp Saham dan Analisis Saham

Tianjin Pharmaceutical Da Ren Tang Group Corp Penilaian berdasarkan KGV, EBIT, dan KUV historis

Tianjin Pharmaceutical Da Ren Tang Group Corp Jumlah Saham CNE000001808 ·

Pendapatan, EBIT dan Laba per Saham

Pendapatan per Saham

EBIT per Saham

Pendapatan per Saham

Nilai yang Diharapkan

Tianjin Pharmaceutical Da Ren Tang Group Corp Pemecahan Saham

Tianjin Pharmaceutical Da Ren Tang Group Corp Dividen Saham CNE000001808 ·

Dividen

Tinjauan atas Dividen

Interpretasi dan Penggunaan

Strategi Investasi

Tianjin Pharmaceutical Da Ren Tang Group Corp Sejarah Dividen

Tianjin Pharmaceutical Da Ren Tang Group Corp Rasio Pembayaran Dividen CNE000001808 ·

Ausschüttungsquote

Apa itu rasio pembagian dividen tahunan?

Cara Menginterpretasikan Data

Penggunaan Data untuk Investasi

Tianjin Pharmaceutical Da Ren Tang Group Corp Sejarah Rasio Pembagian Dividen

Tianjin Pharmaceutical Da Ren Tang Group Corp Estimasi Pendapatan

Tianjin Pharmaceutical Da Ren Tang Group Corp Kejutan Laba

Rating Eulerpool ESG untuk saham Tianjin Pharmaceutical Da Ren Tang Group Corp

Eulerpool World ESG Rating (EESG©)

47/ 100

🌱 Environment

👫 Social

🏛️ Governance

Lingkungan (Environment)

Sosial (Social)

Tata Kelola Perusahaan (Governance)

Tianjin Pharmaceutical Da Ren Tang Group Corp Struktur Pemegang Saham Aktie

Tianjin Pharmaceutical Da Ren Tang Group Corp Rantai pasokan

Pertanyaan Umum tentang Saham Tianjin Pharmaceutical Da Ren Tang Group Corp

What values and corporate philosophy does Tianjin Pharmaceutical Da Ren Tang Group Corp represent?

In which countries and regions is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily present?

Ticker
600329.SS

ISIN
CNE000001808